Sarah Condella - Feb 21, 2024 Form 4 Insider Report for EXACT SCIENCES CORP (EXAS)

Signature
/s/ Sarah Condella by Mark R. Busch, attorney-in-fact
Stock symbol
EXAS
Transactions as of
Feb 21, 2024
Transactions value $
-$60,557
Form type
4
Date filed
2/23/2024, 07:57 PM
Previous filing
Feb 22, 2024
Next filing
Feb 26, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EXAS Common Stock Award $0 +2.03K +2.84% $0.00 73.7K Feb 21, 2024 Direct F1
transaction EXAS Common Stock Sale -$60.6K -1.01K -1.37% $59.78 72.7K Feb 22, 2024 Direct F2, F3
holding EXAS Common Stock 5.73K Feb 21, 2024 Held in 401(k) Plan
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Represents shares of common stock received upon settlement of a performance share unit award on February 21, 2024.
F2 Represents shares sold pursuant to a Sell-to-Cover Rule 10b5-1 Plan to pay withholding taxes due in connection with the vesting of certain performance stock units.
F3 In addition to the shares of Common Stock reported on this Form 4, which total 78,405 shares, Ms. Condella also holds, in the aggregate, an additional 81,149 vested and unvested options to purchase shares of Common Stock and restricted stock units, with each restricted stock unit representing a contingent right to receive one share of Common Stock.